• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Distribution channel
o Market segments
o Comparison by Distribution channel
o Retail stores – Market size and forecast 2020-2025
o Online stores – Market size and forecast 2020-2025
o Market opportunity by Distribution channel
• Customer landscape
o Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Afaxys Pharma LLC
o Combe Inc.
o HLL Lifecare Ltd.
o Lupin Ltd.
o Mankind Pharma Ltd.
o Perrigo Co. Plc
o Piramal Enterprises Ltd.
o Sun Pharmaceutical Industries Ltd.
o Syzygy Healthcare LLC
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: Retail stores – Market size and forecast 2020-2025 ($ million)
• 22: Retail stores – Year-over-year growth 2020-2025 (%)
• 23: Online stores – Market size and forecast 2020-2025 ($ million)
• 24: Online stores – Year-over-year growth 2020-2025 (%)
• 25: Customer landscape
• 26: Impact of drivers and challenges
• 27: Vendor landscape
• 28: Landscape disruption
• 29: Industry risks
• 30: Vendors covered
• 31: Market positioning of vendors
• 32: Afaxys Pharma LLC – Overview
• 33: Afaxys Pharma LLC – Business segments
• 34: Afaxys Pharma LLC – Key offerings
• 35: Afaxys Pharma LLC – Key customers
• 36: Afaxys Pharma LLC – Segment focus
• 37: Combe Inc. – Overview
• 38: Combe Inc. – Product and service
• 39: Combe Inc. – Key offerings
• 40: Combe Inc. – Key customers
• 41: Combe Inc. – Segment focus
• 42: HLL Lifecare Ltd. – Overview
• 43: HLL Lifecare Ltd. – Business segments
• 44: HLL Lifecare Ltd. – Key offerings
• 45: HLL Lifecare Ltd. – Key customers
• 46: HLL Lifecare Ltd. – Segment focus
• 47: Lupin Ltd. – Overview
• 48: Lupin Ltd. – Product and service
• 49: Lupin Ltd. – Key offerings
• 50: Lupin Ltd. – Key customers
• 51: Lupin Ltd. – Segment focus
• 52: Mankind Pharma Ltd. – Overview
• 53: Mankind Pharma Ltd. – Business segments
• 54: Mankind Pharma Ltd. – Key offerings
• 55: Mankind Pharma Ltd. – Key customers
• 56: Mankind Pharma Ltd. – Segment focus
• 57: Perrigo Co. Plc – Overview
• 58: Perrigo Co. Plc – Business segments
• 59: Perrigo Co. Plc – Key offerings
• 60: Perrigo Co. Plc – Key customers
• 61: Perrigo Co. Plc – Segment focus
• 62: Piramal Enterprises Ltd. – Overview
• 63: Piramal Enterprises Ltd. – Business segments
• 64: Piramal Enterprises Ltd. – Key offerings
• 65: Piramal Enterprises Ltd. – Key customers
• 66: Piramal Enterprises Ltd. – Segment focus
• 67: Sun Pharmaceutical Industries Ltd. – Overview
• 68: Sun Pharmaceutical Industries Ltd. – Business segments
• 69: Sun Pharmaceutical Industries Ltd. – Key offerings
• 70: Sun Pharmaceutical Industries Ltd. – Key customers
• 71: Sun Pharmaceutical Industries Ltd. – Segment focus
• 72: Syzygy Healthcare LLC – Overview
• 73: Syzygy Healthcare LLC – Business segments
• 74: Syzygy Healthcare LLC – Key offerings
• 75: Syzygy Healthcare LLC – Key customers
• 76: Syzygy Healthcare LLC – Segment focus
• 77: Currency conversion rates for US$
• 78: Research Methodology
• 79: Validation techniques employed for market sizing
• 80: Information sources
• 81: List of abbreviations
❖ 掲載企業 ❖
Afaxys Pharma LLC, Combe Inc., HLL Lifecare Ltd., Lupin Ltd., Mankind Pharma Ltd., Perrigo Co. Plc, Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC